Yuvimont AL Tablet SR
Images are for reference. Actual packaging may vary.
1 units • OtherPrescription requiredSchedule H
Yuvimont AL Tablet SR
Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
₹145.00
1 units • Other
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Levocetirizine 5 mg
+2 more active ingredients
How It Works
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Ambroxol stimulates the secretion of mucus and reduces its viscosity, facilitating easier expectoration.
Medicine Strength
5 mg
All Active Ingredients
Levocetirizine5 mg
Montelukast10 mg
Ambroxol75 mg
Uses & Benefits
Medical applications
InflammationHeadacheAllergicCough
Yuvimont AL Tablet SR is a combination medication containing Ambroxol 75mg, Levocetirizine 5mg, and Montelukast 10mg, formulated for the management of respiratory conditions characterized by cough, allergic rhinitis, and bronchial asthma. Ambroxol, a mucolytic agent, facilitates the breakdown and clearance of mucus from the respiratory tract, thereby improving airway patency and reducing cough severity.
Read full descriptionShow less
Levocetirizine, a selective second-generation antihistamine, alleviates symptoms associated with allergic reactions such as sneezing, nasal congestion, and itching by inhibiting peripheral histamine H1 receptors without causing significant sedation. Montelukast, a leukotriene receptor antagonist, prevents bronchoconstriction and inflammation by blocking leukotriene D4 receptors in the airways, thus aiding in the control and prevention of asthma symptoms and exercise-induced bronchospasm.
The sustained-release formulation ensures prolonged therapeutic effects, enhancing patient compliance by reducing dosing frequency. Yuvimont AL Tablet SR is indicated for patients requiring simultaneous management of mucus hypersecretion, allergic symptoms, and bronchial hyperresponsiveness. It should be used under medical supervision, with caution in patients with hepatic or renal impairment.
Adverse effects may include headache, gastrointestinal disturbances, and drowsiness. Consultation with a healthcare professional is recommended prior to initiation of therapy.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Yuvimont AL Tablet SR
